Subscribe (free)
About NaturalNews
Contact Us
Write for NaturalNews
Media Info
Advertising Info
Bone drugs

Taking bone drugs may give you cancer

Thursday, December 09, 2010 by: David Gutierrez, staff writer
Tags: bone drugs, cancer, health news

Most Viewed Articles

(NaturalNews) Osteoporosis drugs, already coming under fire for actually weakening people's bones rather than strengthening them, may pose another risk: esophageal cancer.

In a study published in the British Medical Journal, researchers from Oxford University followed 3,000 people between the ages of 60 and 79 who were taking drugs in the bisphosphonate family, such as Actonel, Boniva and Fosamax. After five years, the participants' risk of esophageal cancer doubled relative to those not on such drugs.

"Those subjects who filled 10 or more prescriptions for oral biphosphonates had nearly twice the chance of contracting throat cancer than those who were not taking the drugs," the researchers wrote. The effect remained strong even after researchers adjusted for other potential risk factors such as age, gender, and weight.

Bisphosphonates, which are meant to interfere with the process by which the body breaks down and rebuilds bones as part of normal maintenance activities, are already known to irritate the esophagus.

The drugs have become widely popular in recent years, such that one in 10 British women over the age of 70 is now taking one. Yet alarming reports of side effects are starting to emerge, including concerns that the drugs actually increase the risk of fractures.

"Some people taking Actonel or Fosamax have developed osteonecrosis of the jaw, a condition in which part of the jawbone dies," write Joe Graedon and Teresa Graedon in their book Best Choices From the People's Pharmacy.

"Our findings are part of a wider picture," lead researcher Jane Green said. "Bisphosphonates are being increasingly prescribed to prevent fracture and what is lacking is reliable information on the benefits and risks of their use in the long term."

Although the overall risk of throat cancer remained small even in those taking the drugs, the findings suggest an extra reason for caution.

"Anyone who is taking these drugs and is worried about their risk of cancer should talk to their doctor," said Laura Bell of Cancer Research UK.

Sources for this story include: http://www.bbc.co.uk/news/health-11166308; http://www.drugalert.org/news/2010/09/09/fos....

Join the Health Ranger's FREE email newsletter
Get breaking news alerts on GMOs, fluoride, superfoods, natural cures and more...
Your privacy is protected. Unsubscribe at any time. | Learn more...

comments powered by Disqus

Natural News Wire (Sponsored Content)

Science News & Studies
Medicine News and Information
Food News & Studies
Health News & Studies
Herbs News & Information
Pollution News & Studies
Cancer News & Studies
Climate News & Studies
Survival News & Information
Gear News & Information
News covering technology, stocks, hackers, and more

Get alerted on heavy metals and pesticide test results for foods and supplements

Natural News is about to begin releasing lab test results for off-the-shelf food, supplement and pet food products, covering heavy metals, nutritive minerals, pesticides and herbicides. These details will be released exclusively to Natural News email newsletter subscribers (FREE) and will NOT be publicly posted on the website. To be alerted, join our free email newsletter now, and watch for lab test results in the weeks ahead.

Enter your email address below to subscribe to our email announcement list (but don't use gmail). Your privacy is protected and you can unsubscribe at any time. If you don't join our email list, you may never see our valuable content again via Facebook, Google or YouTube. CENSORSHIP has now reached EXTREME levels across the 'net. The truth is being suffocated. Subscribe now if you want to escape the delusional bubble of false reality being pushed by Google and Facebook.

Once you click subscribe, we will send you an email asking you to confirm your free subscription.